Temas

En este página los lectores pueden obtener una lista de documentos clasificados por temas. Haga clic en el título de tema para ver los sub-títulos, o para volver a los temas principales. Haga clic en el icono de un subtítulo para obtener los documentos relacionados. Las publicaciones están disponibles en formato HTML, PDF

, DOC

o XLS

. Haga clic por favor en el icono correspondiente para acceder a la publicación.


		Página inicial de la OMS

		Sistemas y Servicios de Salud, OMS

		Medicamentos, OMS

		Sitios OMS

		Página inicial de Publicaciones y Documentación de Medicamentos

		Buscar

		Títulos A-Z

		Temas

		Palabras clave

		Series y Periódicas

		Publicadores

		Autores A-Z

		Regiones

		Países

		Índice

		Subcolecciones

		Public sub-collections

Publicaciones de la OMS - Publicaciones ajenas a la OMS - Todos

Inglés - Francés - Español - Ruso

Ampliar el menú subcolecciones.

166 documentos en 4 páginas

Siguiente » | Todos | Detalles

Mostrar Todos | Ocultar Todos

Medicine Access and Rational Use

Pricing

Abrir este documento y ver su índice de contenido

Título:	10 Stories that Mattered in Access to Medicines in 2011 - Médecins Sans Frontières (MSF Access Campaign)
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Año:	2011 Páginas: 13
Publicadores:	Médecins sans Frontières (MSF)
Regiones:	Global

Título:	Access to Care for Patients with Insulin-requiring Diabetes in Developing Countries. Case Studies of Mozambique and Zambia
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Beran, David; De Courten, Maximilian; Yudkin, J. S.
Año:	2005 Páginas: 5
Regiones:	África (AFRO)
Países:	Mozambique; Zambia

Título:	Access to Drugs for HIV/AIDS and Related Opportunistic Infections in Nigeria. A Status Report on the Sociopolitical, Economic, And Policy Climate on Drug Availability for People Living with HIV/AIDS (PLWHA) and Recommendations for Future Access
Temas:	Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Rational Use Medicine Access and Rational Use > Supply Management
Autore:	Obileye, Olatubosun; Peterson, Kristin
Año:	2002 Páginas: 93
Publicadores:	POLICY Project/Nigeria
Países:	Nigeria

Título:	Access to Essential Medicines and Standard Treatment for Chronic Diseases
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Kotwani, Anita
Año:	2010 Páginas: 3
Regiones:	Global
Países:	India

Título:	Access to Inhaled Corticosteroids is Key to Improving Quality of Care for Asthma in Developing Countries
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Aït-Khaled, Nadia; Billo, Nils E.; Bissell, K.; Enarson, Donald A
Año:	2007 Páginas: 7
Regiones:	Global

Título:	Action Needed: Spiraling Drug Prices Empty Russian Pockets
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Bonch-Osmolovskiy, Mikhail; Marquez, Patricio
Año:	2010 Páginas: 4
Publicadores:	The World Bank (WB)
Países:	Federación de Rusia

Título:	Affordability of Medicines in Fiji
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Bailey, Murray
Año:	2004 Páginas: 15
Publicadores:	Fiji School of Medicine
Países:	Fiji

Título:	Analyzing and Controlling Pharmaceutical Expenditures. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 40)
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Autore:	Rankin, James
Año:	2012 Páginas: 33
Publicadores:	Management Sciences for Health (MSH)
Documentos relacionados:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Enlaces relacionados:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Regiones:	Global

Título:	Are Patents Impeding Medical Care and Innovation?
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Autore:	Gold, E. Richard; Harland-Logan, Sarah; Kaplan, Warren; N-Marandi, Sevil; Orbinski,James
Año:	2009 Páginas: 5
Regiones:	Global

Título:	Are Pharmaceuticals Inexpensive in Norway? A Comparison of Prices of Prescription Pharmaceuticals between Norway and Nine West European Countries. SNF Report No. 05/08
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune
Año:	2008 Páginas: 73
Publicadores:	Institute for Research in Economics and Business Administration, Bergen, Norway
Enlaces relacionados:	http://www.regjeringen.no/en/dep/hod/Whats-new/News/2008/report-on-pharmaceutical-prices.html?id=514810
Regiones:	Europa (EURO)
Países:	Noruega

Título:	Assessing the Population Health Impact of Market Interventions to Improve Access to Antiretroviral Treatment
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Bärnighausen, Till; Kyle, Margaret; Salomon, Joshua A; Waning, Brenda
Año:	2011 Páginas: 10
Publicadores:	Health Policy and Planning
Regiones:	Global

Título:	Australian Schedule of Pharmaceutical Benefits, 1 September 2012 - 30 September 2012
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Selection
Año:	2012 Páginas: 1031
Publicadores:	Australian Government - Department of Health and Ageing
Enlaces relacionados:	http://pbs.gov.au/browse/publications
Países:	Australia

Título:	Availability, Price and Affordability of Asthma Medicines in Five Indian States
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Kotwani, Anita
Año:	2009 Páginas: 6
Publicadores:	India - University of Delhi, Department of Pharmacology
Países:	India

Título:	Availability, Price and Affordability of Cardiovascular Medicines: A Comparison Across 36 Countries Using WHO / HAI Data
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Cameron, Alexandra; Ewen, Margaret; Laing, Richard; van Mourik, Maaike SM
Año:	2010 Páginas: 9
Regiones:	Global

Título:	Brand-Name Prescription Drug Pricing. Lack of Therapeutically Equivalent Drugs and Limited Competition May Contribute to Extraordinary Price Increases
Temas:	Medicine Access and Rational Use > Pricing
Año:	2009 Páginas: 40
Publicadores:	United States Government Accountability Office
Países:	Estados Unidos de América

Título:	A Call to Make Valuable Innovative Medicines Accessible in the European Union. Recommendations for a Coordinated Action to Stimulate, Measure and Valorise Pharmaceutical Innovation. Background Report for the Ministerial Conference, 23-24 September 2010 [French]
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Año:	2010 Páginas: 55
Publicadores:	European Union - Belgian Presidency of the Council of the European Union
Regiones:	Europa (EURO)

Título:	Can the Public Central Medical Supplies Corporation of Sudan Balance a Policy for Delivering Low-cost Medicines Whilst Maintaining Quality?
Temas:	Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Autore:	Ali, Gamal Khalafalla Mohamed
Año:	2010 Páginas: 7
Países:	Sudán

Título:	Children’s Medicines in Chad: An Investigation into Availability and Factors Impacting Access [French]
Temas:	Medicine Access and Rational Use > Better Medicines for Children Medicine Access and Rational Use > Pricing
Año:	2011 Páginas: 7
Publicadores:	Ecumenical Pharmaceutical Network
Documentos relacionados:	Children’s Medicines in Kenya: An Investigation into Availability and Factors Impacting Access Children’s Medicines in Uganda: An Investigation into Availability and Factors Impacting Access Children’s Medicines in Ghana: An Investigation into Availability and Factors Impacting Access
Enlaces relacionados:	http://www.epnetwork.org/childrens-medicines
Países:	Chad

Título:	Children’s Medicines in Ghana: An Investigation into Availability and Factors Impacting Access
Temas:	Medicine Access and Rational Use > Better Medicines for Children Medicine Access and Rational Use > Pricing
Año:	2011 Páginas: 5
Publicadores:	Ecumenical Pharmaceutical Network
Documentos relacionados:	Children’s Medicines in Chad: An Investigation into Availability and Factors Impacting Access Children’s Medicines in Kenya: An Investigation into Availability and Factors Impacting Access Children’s Medicines in Uganda: An Investigation into Availability and Factors Impacting Access
Enlaces relacionados:	http://www.epnetwork.org/childrens-medicines
Países:	Ghana

Título:	Children’s Medicines in Kenya: An Investigation into Availability and Factors Impacting Access
Temas:	Medicine Access and Rational Use > Better Medicines for Children Medicine Access and Rational Use > Pricing
Año:	2011 Páginas: 6
Publicadores:	Ecumenical Pharmaceutical Network
Documentos relacionados:	Children’s Medicines in Ghana: An Investigation into Availability and Factors Impacting Access
Enlaces relacionados:	http://www.epnetwork.org/childrens-medicines
Países:	Kenya

Título:	Children’s Medicines in Uganda: An Investigation into Availability and Factors Impacting Access
Temas:	Medicine Access and Rational Use > Better Medicines for Children Medicine Access and Rational Use > Pricing
Año:	2011 Páginas: 6
Publicadores:	Ecumenical Pharmaceutical Network
Documentos relacionados:	Children’s Medicines in Chad: An Investigation into Availability and Factors Impacting Access Children’s Medicines in Kenya: An Investigation into Availability and Factors Impacting Access Children’s Medicines in Ghana: An Investigation into Availability and Factors Impacting Access
Enlaces relacionados:	http://www.epnetwork.org/childrens-medicines
Países:	Uganda

Título:	Chronic Airflow Limitation in Developing Countries: Burden and Priorities
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Aït-Khaled, Nadia; El Sony, Asma; Eltigani, Mai; Enarson, Donald A; Ottmani, Salah; Sepulveda, Ricardo
Año:	2007 Páginas: 10
Regiones:	Global

Título:	A Comparative Evaluation of Price and Quality of Some Branded Versus Branded–generic Medicines of the Same Manufacturer in India
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Kotwani, Anita; Nanda, Arun; Singal, G.L.
Año:	2011 Páginas: 7
Países:	India

Título:	Controlling Medicine Prices in Sudan: The Challenge of the Recently Established Medicines Regulatory Authority
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Ali, G.K.M.; Yahia, A.Y.
Año:	2012 Páginas: 10
Países:	Sudán

Título:	Corporate Responsibilities for Access to Medicines
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Autore:	Leisinger, Klaus M.
Año:	2009 Páginas: 21
Publicadores:	Novartis Foundation for Sustainable Development
Documentos relacionados:	Poverty, Disease and Medicines in Low- and Middle-income Countries: The Roles and Responsibilities of Pharmaceutical Corporations
Regiones:	Global

Título:	The Cost of Universal Health Care in India: A Model Based Estimate
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Bahuguna, Pankaj; Bharaj, Gursimer; Kaur, Manmeet; Kumar, Rajesh; Kumar, Vishal; Pinto, Andrew D.; Prinja, Shankar; Sharma, Atul; Tripathy, Jaya Prasad
Año:	2012 Páginas: 9
Países:	India

Título:	Cost-containment Policies in Public Pharmaceutical Spending in the EU. Economic Papers 461. September 2012 (European Economy/European Commission)
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Carone, Giuseppe; Schwierz, Christoph; Xavier, Ana
Año:	2012 Páginas: 67
Publicadores:	European Commission (EC)
Enlaces relacionados:	http://ec.europa.eu/economy_finance/publications/economic_paper/2012/ecp461_en.htm
Regiones:	Europa (EURO); EU European Union

Título:	Decrease in Prices of Antiretroviral Drugs for Developing Countries: From Political “Philanthropy” to Regulated Markets?
Temas:	Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Autore:	Cenival, de Marie; Cisse, Boubou; Comiti, Caroline; Duran, Ségolène; Gaudry, Marion; Lucchini, Stéphane; Moatti, Jean-Paul
Año:	2003 Páginas: 44
Regiones:	Global

Título:	Diabetes Care in Sub-Saharan Africa
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Beran, David; Yudkin, J. S.
Año:	2006 Páginas: 7
Regiones:	SSA Sub-Saharan Africa

Título:	The Diabetes UK Mozambique Twinning Programme. Results of Improvements in Diabetes Care in Mozambique: A Reassessment 6 Years Later Using the Rapid Assessment Protocol for Insulin Access. Special Report
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Beran, David; Matos, Carla Silva; Yudkin, J. S.
Año:	2010 Páginas: 8
Regiones:	SSA Sub-Saharan Africa
Países:	Mozambique

Título:	Differential Pricing for Pharmaceuticals. Review of Current Knowledge, New Findings and Ideas for Action
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Yadav, Prashant
Año:	2010 Páginas: 57
Publicadores:	DFID - UK Department for International Development MIT-Zaragoza International Logistics Program
Regiones:	Global

Título:	Direct Costs and Availability of Diabetes Medicines in Low-income and Middle-Income Countries
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Volman, Birgit
Año:	2008 Páginas: 99
Publicadores:	WHO Collaborating Centre for Phamacoepidemiology and Pharmaceutical Policy Analysis (Utrecht, Netherlands) Health Action International (HAI)
Regiones:	Global

Título:	Discounts and Rebates Granted to Public Payers for Medicines in European Countries - Southern Med Review Vol 5 Issue 1 July 2012
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Bucsics, Anna; Habl, Claudia; Piessnegger, Jutta; Vogler, Sabine; Zimmermann, Nina
Año:	2012 Páginas: 9
Regiones:	Europa (EURO)

Título:	Does Price Reveal Poor-quality Drugs? Evidence from 17 Countries
Temas:	Medicine Access and Rational Use > Pricing Quality and Safety: Medicines > Quality Assurance
Autore:	Bate, Roger; Jin, Ginger Zhe; Mathur. Aparna
Año:	2011 Páginas: 43
Publicadores:	National Bureau of Economic Research, Cambridge, USA
Regiones:	Global

Título:	DR-TB Drugs under the Microscope - Sources and Prices for Drug-Resistant Tuberculosis Medicines [Russian]
Temas:	Medicine Access and Rational Use > Antimicrobial Drug Resistance Medicine Access and Rational Use > Pricing
Año:	2011 Páginas: 48
Publicadores:	International Union Against Tuberculosis and Lung Disease (The Union) Médecins sans Frontières (MSF)
Documentos relacionados:	DR-TB Drugs Under the Microscope - Sources and Prices for Drug-Resistant Tuberculosis Medicines. 2nd Edition, November 2012
Regiones:	Global

Título:	DR-TB Drugs Under the Microscope - Sources and Prices for Drug-Resistant Tuberculosis Medicines. 2nd Edition, November 2012
Temas:	Medicine Access and Rational Use > Antimicrobial Drug Resistance Medicine Access and Rational Use > Pricing
Año:	2012 Páginas: 48
Publicadores:	International Union Against Tuberculosis and Lung Disease (The Union) Médecins sans Frontières (MSF)
Documentos relacionados:	DR-TB Drugs under the Microscope - Sources and Prices for Drug-Resistant Tuberculosis Medicines
Enlaces relacionados:	http://msfaccess.org/content/dr-tb-drugs-under-microscope-2nd-edition
Regiones:	Global

Título:	Dying of Diabetes
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Gale, Edwin AM
Año:	2006 Páginas: 3
Regiones:	Global; SSA Sub-Saharan Africa

Título:	Economics for Pharmaceutical Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 10)
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Henry, David
Año:	2012 Páginas: 14
Publicadores:	Management Sciences for Health (MSH)
Documentos relacionados:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Enlaces relacionados:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Regiones:	Global

Título:	The Effect of Implementing “Medicines Zero Mark-up Policy” in Beijing Community Health Facilities - Southern Med Review Vol 5 Issue 1 July 2012
Temas:	Medicine Information and Evidence for Policy > Information and Publications Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Autore:	Cheng, Wei; Fan, Dehui; Fang, Yunyun; Li, Jiao; Shi, Xuefeng; Sun, Jing
Año:	2012 Páginas: 4
Países:	China

Título:	Ensuring Efficiency in Pharmaceutical Expenditures, in OECD, Achieving Better Value for Money in Health Care, 2009. (Pages :101–128). OECD Publishing
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Autore:	Docteur, Elizabeth; Paris, Valérie
Año:	2009 Páginas: 30
Publicadores:	Organisation for Economic Co-operation and Development (OECD)
Enlaces relacionados:	http://dx.doi.org/10.1787/9789264074231-5-en
Regiones:	Global

Título:	Equitable Pricing of Newer Essential Medicines for Developing Countries: Evidence for the Potential of Different Mechanisms
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Grace, Cheri
Año:	2003 Páginas: 83
Publicadores:	London Business School
Regiones:	Global

Título:	Establishing a Baseline to Monitor Public Health Implications of New Intellectual Property Rights Regime on Pharmaceuticals in Sri Lanka - 2010
Temas:	Medicine Access and Rational Use > Pricing
Autore:	Weerasinghe, Manuj C.
Año:	2010 Páginas: 68
Publicadores:	Health Action International - Asia Pacific Sri Lanka - Department of Community Medicine, Faculty of Medicine, University of Colombo
Países:	Sri Lanka

Título:	Evaluation of the Revolving Drug Fund (RDF) Project in the Sudan: The Leadership’s Perspectives
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Año:	2008 Páginas: 78
Publicadores:	Sudan National Ministry of Health
Países:	Sudán

Título:	Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand. Document to Support Strengthening of Social Wisdom on the Issue of Drug Patent
Temas:	Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Año:	2007 Páginas: 104
Publicadores:	Thailand - Ministry of Health Thailand - National Health Security Office
Países:	Tailandia

Título:	Financial Impact of Medicines Patent Pool: I‐MAK/ITPC Counter Analysis. This Report Supplements Measuring the Impact of Medicines Patent Pool Licenses: A Civil Society Assessment (Inserted)
Temas:	Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Año:	2011 Páginas: 4
Publicadores:	Initiative for Medicines, Access & Knowledge (I-MAK)
Documentos relacionados:	Voluntary Licensing: Optimizing Global Efforts and Measuring Impact Voluntary Licensing Practices in the Pharmaceutical Sector: An Acceptable Solution to Improving Access to Affordable Medicines?
Enlaces relacionados:	http://www.i-mak.org/publications/
Regiones:	Global

Título:	Financing, Pricing, and Utilization of Pharmaceuticals in China: The Road to Reform. China Health Policy Notes, No. 01, June 2010
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
Año:	2010 Páginas: 70
Publicadores:	The World Bank (WB)
Países:	China

Título:	Five Years into the Product Patent Regime: India’s Response. UNDP, 2010
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Autore:	Chaudhuri, Sudip; Gopakumar, K. M.; Park, Chan
Año:	2010 Páginas: 184
Publicadores:	United Nations Development Programme (UNDP)
Países:	India

Título:	Generic Policies and the Generics Paradox
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Autore:	Vandoros, Sotirios
Año:	2008 Páginas: 12
Publicadores:	European Observatory on Health Systems and Policies
Documentos relacionados:	Generic Policies: Rhetoric vs. Reality Maximising the Benefits from Generic Competition
Enlaces relacionados:	http://www.euro.who.int/en/who-we-are/partners/observatory/euro-observer
Regiones:	Global; Europa (EURO)

Título:	Generic Policies: Rhetoric vs. Reality
Temas:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Autore:	Kanavos, Panos
Año:	2008 Páginas: 12
Publicadores:	European Observatory on Health Systems and Policies
Documentos relacionados:	Generic Policies and the Generics Paradox Maximising the Benefits from Generic Competition
Enlaces relacionados:	http://www.euro.who.int/en/who-we-are/partners/observatory/euro-observer
Regiones:	Global; Europa (EURO)

Título:	The Global Pediatric Antiretroviral Market: Analyses of Product Availability and Utilization Reveal Challenges for Development of Pediatric Formulations and HIV/AIDS Treatment in Children
Temas:	Medicine Access and Rational Use > Better Medicines for Children Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Autore:	Bärnighausen, Till; Diedrichsen, Ellen; Jambert, Elodie; Li, Yun; Moon, Suerie; Pouw, Mieke; Waning, Brenda
Año:	2010 Páginas: 14
Regiones:	Global


	1 2 3 4 Siguiente »

Última actualización: le 3 mayo 2013